bcma-targeted car-ts and their role in late-relapse multiple myeloma
Published 1 year ago • 164 plays • Length 5:19Download video MP4
Download video MP3
Similar videos
-
6:10
panel discusses novel bcma-targeted car-t therapies in the myeloma pipeline
-
10:18
ide-cel; bb2121, a bcma-targeted car t-cell therapy, in patients with rrmm: initial karmma results
-
4:17
clinical outcomes of relapsed/refractory multiple myeloma patients after bcma-targeted car t the...
-
0:53
incorporating bcma-targeted car-t therapy in the frontline treatment of multiple myeloma
-
58:19
sequencing bcma myeloma therapies
-
1:12
causes for relapse in multiple myeloma with car t cells
-
0:36
promise of gprc5d-targeted car-t therapies in multiple myeloma
-
7:10
bcma-targeted car t-cell therapy for myeloma
-
7:42
car t-cell therapy for patients with late relapsed/refractory myeloma - blood cancers video library
-
4:51
promising bcma-targeting car-t cells for relapsed myeloma
-
6:28
phase i crb-402 study of the bcma-targeted car t cell therapy bb21217 in pts w/rr multiple myeloma
-
11:01
targeting bcma for r/r myeloma
-
44:36
anti-bcma bispecific antibody for myeloma relapse after car t cells
-
3:24
bcma-targeted therapies and multiple myeloma
-
5:24
a novel car-t cell therapy targeting bcma is highly effective for pts with relapsed multiple myeloma
-
48:17
faqs on multiple myeloma following relapse
-
52:45
car t-cell therapy in multiple myeloma
-
8:36
alnuctamab, a bcma x cd3 t-cell engager, in pts with relapsed/refractory multiple myeloma
-
31:00
car t-cells multiple myeloma: adam sperling, md, phd